Exogene Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $187K

  • Investors
  • 14

Exogene General Information

Description

Operator of a biotechnology platform intended to discover novel T-cell receptor-based therapies to treat advanced solid tumors. The company helps to identify rare, anti-cancer TCRs that can be used to develop TCR-based therapies, by combining deep learning and high-throughput TCR screening in the lab, enabling healthcare providers to develop cell therapies to rejuvenate the immune system and prevent disease.

Contact Information

Website
www.exogene.co.uk
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wood Centre for Innovation, Stansfeld Park
  • Quarry Road, Headington
  • Oxford OX3 8SB
  • England, United Kingdom
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences, Oncology
Corporate Office
  • Wood Centre for Innovation, Stansfeld Park
  • Quarry Road, Headington
  • Oxford OX3 8SB
  • England, United Kingdom

Exogene Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exogene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Equity Crowdfunding 10-Oct-2025 $187K Completed Generating Revenue
11. Accelerator/Incubator 01-Oct-2024 Completed Generating Revenue
10. Grant 01-Jun-2024 Completed Generating Revenue
9. Grant 01-Mar-2024 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
7. Grant 01-Dec-2023 Completed Generating Revenue
6. Early Stage VC 01-Nov-2023 Completed Generating Revenue
5. Grant 01-Sep-2023 Completed Generating Revenue
4. Grant 01-Nov-2022 $395K $2M Completed Generating Revenue
3. Seed Round 25-Apr-2022 $2M $2M Completed Generating Revenue
To view Exogene’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Exogene Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology platform intended to discover novel T-cell receptor-based therapies to treat advanced solid
Discovery Tools (Healthcare)
Oxford, United Kingdom
8 As of 2023

South San Francisco, CA
 

Oxford, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Exogene Competitors (94)

One of Exogene’s 94 competitors is ArsenalBio, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ArsenalBio Venture Capital-Backed South San Francisco, CA
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
GentiBio Venture Capital-Backed Cambridge, MA
Centrose Venture Capital-Backed Madison, WI
Healx Venture Capital-Backed Cambridge, United Kingdom
You’re viewing 5 of 94 competitors. Get the full list »

Exogene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Exogene Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
University of Toronto University
BioIndustry Association Accelerator/Incubator
Beresford Ventures Venture Capital Minority
Innovate UK Government
Entrepreneurs First Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

Ready to get started?

Request a free trial

Exogene FAQs

  • When was Exogene founded?

    Exogene was founded in 2019.

  • Where is Exogene headquartered?

    Exogene is headquartered in Oxford, United Kingdom.

  • What is the size of Exogene?

    Exogene has 8 total employees.

  • What industry is Exogene in?

    Exogene’s primary industry is Discovery Tools (Healthcare).

  • Is Exogene a private or public company?

    Exogene is a Private company.

  • What is Exogene’s current revenue?

    The current revenue for Exogene is .

  • How much funding has Exogene raised over time?

    Exogene has raised $2.19M.

  • Who are Exogene’s investors?

    University of Toronto, BioIndustry Association, Beresford Ventures, Innovate UK, and Entrepreneurs First are 5 of 14 investors who have invested in Exogene.

  • Who are Exogene’s competitors?

    ArsenalBio, Oxford Biotherapeutics, GentiBio, Centrose, and Healx are some of the 94 competitors of Exogene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process